Sekisui Chemical (4204) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
16 Nov, 2025Executive summary
Q1 net sales reached ¥305.1 billion (+2.1% YoY), and operating profit rose to ¥21.2 billion (+5.1% YoY), both record highs, while ordinary profit and profit attributable to owners declined due to FX losses and lower gains on investment securities.
Group sales and profits grew, led by strong Housing segment performance, offsetting declines in other segments.
Despite slumps in domestic housing, non-housing construction, and global auto markets, sales increased thanks to higher housing sales and renovation orders; one-time expenses in Europe and FX losses weighed on results.
1H FY2025 forecasts project record high net sales and operating profit, with interim dividend per share expected to rise to ¥40.
Financial highlights
Net sales: ¥305.1 billion (+2.1% YoY); operating profit: ¥21.2 billion (+5.1% YoY); ordinary profit: ¥20.2 billion (−23.9% YoY); profit attributable to owners: ¥13.1 billion (−44.5% YoY).
Gross profit margin improved to 32.4% (+0.2% YoY); EBITDA for Q1 was ¥35.3 billion (+¥2.0 billion YoY).
EPS: ¥31.61 (down from ¥56.47 YoY); comprehensive income: ¥16.7 billion (−49.0%).
First half net sales forecast: ¥639.2 billion (+¥10.1 billion YoY); operating profit: ¥48.9 billion (+¥0.2 billion YoY), both record highs.
Interim dividend planned to increase by ¥3 to ¥40 per share.
Outlook and guidance
First-half net sales forecast revised down to ¥639.2 billion (−2.9% from previous forecast), but operating and ordinary profit guidance unchanged; full-year forecast remains at ¥1,364.5 billion net sales and ¥82.0 billion profit attributable to owners.
Q2 FX assumption set at ¥145/USD; direct impact of US tariffs expected to be minimal.
Q2 auto production and smartphone shipments expected slightly below previous outlook.
First half operating profit expected to be on track despite net sales projected to fall short of plan.
Latest events from Sekisui Chemical
- Record sales achieved, but profits fell on impairment and one-time costs.4204
Q3 20263 Feb 2026 - Record Q1 profits and raised first-half outlook driven by strong demand and FX gains.4204
Q1 20252 Feb 2026 - Record-high H1 sales and profit drive upward guidance and continued dividend growth.4204
Q2 202517 Jan 2026 - Record sales and profits achieved, with full-year profit and dividend forecasts raised.4204
Q3 20259 Jan 2026 - Record profits and sales achieved, with further gains and dividend growth targeted for FY 2025.4204
Q4 202524 Dec 2025 - Record sales but lower profits and revised guidance amid weak auto and EV demand.4204
Q2 20261 Nov 2025